MKI67 and breast carcinoma: In a similar work involving 12 breast cancer patients, Margolis et al. used 18F-FDG as a surrogate for tumour aggressiveness and metastatic potential combined with MRI-derived parameters for capillary/vessel permeability (Ktrans and kep) to find correlations with the Ki67 proliferation factor.